Skip to main content

Table 1 Information provided in laypeople language in the online video consent module of the ADAPTABLE trial

From: Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial

∙ Background information on the use of aspirin in cardiovascular diseases;
∙ Description of the clinical equipoise regarding the optimal dose in secondary prevention;
∙ Goals of the ADAPTABLE trial;
∙ Randomization process;
∙ Study outcomes;
∙ Description of participants flow during the study;
∙ Study duration;
∙ Security of personal information;
∙ Side effects of aspirin;
∙ Absence of direct benefits to participate in the trial;
∙ Contact information of the study team.